Stefan Walzer
Impact in
- Geriatrics and Gerontology top 5%
-
- Diabetes Management and Research
- Diabetes Treatment and Management
Papers in
-
- Lung Cancer Treatments and Mutations 22
- Lung Cancer Diagnosis and Treatment 11
- Gastric Cancer Management and Outcomes 10
- Renal cell carcinoma treatment 8
-
- Health Systems, Economic Evaluations, Quality of Life 17
- Economic and Financial Impacts of Cancer 13
- Pharmaceutical Economics and Policy 11
- Co-authors
- Mark Nuijten (7 shared papers)C. Chouaïd (14 shared papers)A. Vergnenègre (14 shared papers)Suela Sulo (6 shared papers)Francesco Grossi (4 shared papers)Philipp Schüetz (6 shared papers)Bernard Escudier (3 shared papers)Helge Bischoff (6 shared papers)
- Journals
- Value in Health (31 papers)ClinicoEconomics and Outcomes Research (8 papers)Lung Cancer (7 papers)Journal of Clinical Oncology (3 papers)ACM Transactions on Algorithms (2 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Stefan Walzer
90 papers receiving 877 citations
Peers
Comparison fields: 5 of 104
- Geriatrics and Gerontology 69
- Endocrinology, Diabetes and Metabolism 149
- Economics and Econometrics 232
- Oncology 210
- Pulmonary and Respiratory Medicine 233
Countries citing papers authored by Stefan Walzer
This map shows the geographic impact of Stefan Walzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Walzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Walzer more than expected).
Fields of papers citing papers by Stefan Walzer
This network shows the impact of papers produced by Stefan Walzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Walzer. The network helps show where Stefan Walzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Walzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 178 | |
| 2 | 2009 | 54 | |
| 3 | 2020 | 50 | |
| 4 | 2006 | 37 | |
| 5 | 2021 | 36 | |
| 6 | 2011 | 30 | |
| 7 | 2016 | 29 | |
| 8 | 2019 | 27 | |
| 9 | 2010 | 23 | |
| 10 | 2014 | 22 | |
| 11 | 2013 | 20 | |
| 12 | 2011 | 20 | |
| 13 | 2012 | 19 | |
| 14 | 2012 | 17 | |
| 15 | 2013 | 16 | |
| 16 | 2011 | 15 | |
| 17 | 2010 | 15 | |
| 18 | 2016 | 14 | |
| 19 | 2010 | 13 | |
| 20 | 2018 | 13 |
About Stefan Walzer
Stefan Walzer is a scholar working on Pulmonary and Respiratory Medicine, Economics and Econometrics, Oncology, Physiology and Artificial Intelligence, having authored 99 papers that have together received 901 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (22 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers), Economic and Financial Impacts of Cancer (13 papers), Lung Cancer Diagnosis and Treatment (11 papers), Pharmaceutical Economics and Policy (11 papers), Gastric Cancer Management and Outcomes (10 papers), Renal cell carcinoma treatment (8 papers) and Colorectal Cancer Treatments and Studies (8 papers). The work is most often cited by research in Geriatrics and Gerontology (69 citations), Endocrinology, Diabetes and Metabolism (149 citations), Economics and Econometrics (232 citations), Oncology (210 citations) and Pulmonary and Respiratory Medicine (233 citations). Stefan Walzer has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Mark Nuijten, C. Chouaïd, A. Vergnenègre, Suela Sulo, Francesco Grossi, Philipp Schüetz, Bernard Escudier, Helge Bischoff, Javier de Castro and Ernst Eckehardt Müller. Their work appears in journals such as Value in Health, ClinicoEconomics and Outcomes Research, Lung Cancer, Journal of Clinical Oncology and ACM Transactions on Algorithms.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.